Antitrust lawsuit against major insurers of USA

Mashrukh Khan: A federal judge in Massachusetts has allowed a major antitrust lawsuit to proceed against health technology firm Zelis Healthcare and five of the nation’s largest insurers, including Aetna, Cigna, Elevance Health, Humana, and UnitedHealth Group. On March 30, 2026, U.S. District Court Judge Brian E. Murphy denied the defendants’ joint motion to dismiss the consolidated class action, ruling that healthcare providers had plausibly alleged an illegal conspiracy to suppress out-of-network reimbursement rates.

The case centers on allegations that the insurers used Zelis’s proprietary repricing tools to systematically reduce payments for services provided outside their networks. Providers claim these tools, including the Established Reimbursement Solution and similar platforms, generated artificially low fee schedules based on shared market data. This practice allegedly coordinated pricing among competitors, functioning as a hub-and-spoke conspiracy that drove down payments far below competitive levels.

Plaintiffs, including Pacific Inpatient Medical Group in California, dental practices in Kansas and Wisconsin, and a chiropractic provider, described severe impacts. One claim from Pacific Inpatient Medical Group was reportedly repriced at a discount exceeding 88 percent of the billed amount. Providers from multiple states argued that they were forced to accept these reduced rates or risk losing access to patients covered by the major payers.

Zelis, a New Jersey-based company specializing in claims integrity and payment optimization, provides the technology that enables insurers to reprice out-of-network claims. The lawsuit contends that the insurers collaborated through Zelis to exchange information and enforce uniform lower reimbursements, violating federal antitrust laws. Defendants had argued that their use of the tools represented legitimate independent pricing decisions and that any reductions benefited policyholders through lower premiums.

Judge Murphy rejected those defenses at the pleading stage, finding sufficient allegations of antitrust injury and standing. He noted that the providers adequately pleaded harm from suppressed payments and that factual disputes over whether the arrangement constituted price-fixing should be resolved through further litigation rather than dismissal.

The ruling consolidates several related suits filed starting in March 2025 and allows discovery to move forward. Legal experts view the decision as a significant development that could influence how insurers and vendors handle out-of-network claims nationwide. Both sides now face a potentially lengthy court battle over practices that affect billions in annual healthcare payments.